MedPath

Effects of bromelain and serrapeptase supplementation on surgical and traumatic wound healing and pain reductio

Not Applicable
Conditions
trauma.
Acute pain due to trauma
G89.11
Registration Number
IRCT20140804018677N6
Lead Sponsor
Research and technology deputy, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Male and non-pregnant female
age>18y
Up to 1 week post trauma or surgery
Wound size between 1-10 cm
tend to use this supplement

Exclusion Criteria

Allergy to bromelain and serrapeptase
Collagen Vascular or autoimmune Diseases
mild-moderate and severe wound according to American infectious disease society criteria
Using steroidal drugs in 2 months prior to study (exp. inhaled steroidal drugs for COPD and asthma and topical steroidal medication
Using antibiotics in a week prior to study
radiation therapy of wound
HBA1c>10
venous insuf?ciency or osteomyelitis
Using immunosuppressant
active malignancies
Renal disorders ((blood urea nitrogen < 21.4 mmol/l, creatinine < 247.5 umol/l) or liver failure
MI in 3 months prior to study
Drug or alcohol abuse

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain of wound (trauma or surgical). Timepoint: Baseline and at the end of the study. Method of measurement: VAS (visual analog scale).;Size of wound (trauma or surgical). Timepoint: Baseline and at the end of the study. Method of measurement: Centimeter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath